Abstract. The structure-activity relationship of sugars inducing secretion of glucagon-like peptide-1 from the gut was examined using intestinal loops prepared from the terminal portion of the ileum of dogs. The plasma glucagon-like peptide-1 concentration in a mesenteric vein draining only the looped region of the intestine was increased after infusion of 139 mmol/l solutions of D\ x=r eq-\ glucose, D-galactose, D-glucuronic acid, 3-0-methyl-D\x=req-\ glucose, maltose, sucrose or maltitol into the intestinal lumen, but not after infusion of solutions of D-fructose, D-fucose, D-mannose, D-xylose or lactose. The increases in plasma glucagon-like peptide-1 concentration correlated with the corresponding increases in glucagon-like immunoreactivity induced by these sugars. The plasma glucose level of the regional mesenteric vein increased significantly from the basal level after instillation of D\ x=r eq-\ glucose, but not after instillation of other sugars. It is suggested that cells of the gut have a glucose sensor for release of products of the glucagon gene and that this sensor has specific steric requirements. The sugars that induced glucagon-like peptide-1 release share the molecular features of electron density near C(6), an equatorial hydroxyl at C(2), and an axial hydroxyl at C(1), which could account for their recognition by the glucose sensor to initiate the releases of glucagon-like peptide-1 and glucagon-like immunoreactivity. (72-108)) and glucagon-like peptide-2 (proglucagon(126-159)), which were flanked by basic dipeptides, potential post-translational cleavage sites (4, 5) Proglucagon is shown to be processed into glicentin (proglucagon 1-69) (6) and the two glucagon-like peptides in the ileum. Recently, the complete amino acid sequences of human and porcine gut GLP-1 have been shown to correspond to that of proglucagon(78-107) amide (7) which was the product of further cleavage and amidation of proglucagon . A synthetic peptide corresponding to proglucagon amide has been reported to have several interesting effects: at physiological concentrations it strongly stimulates insulin secretion (8,9) suppresses gluca¬ gon secretion (10,11), and inhibits acid secretion (12). GLP-1 immunoreactivity has been shown to be released into the circulation after a mixed meal and in response to a glucose load (13). Thus, GLP-1 has been suggested to play an important role in carbohydrate metabolism as an "incretin". How¬ ever, the mechanism of its secretion from the in¬ testinal tract is not known.
glucose, D-galactose, D-glucuronic acid, 3-0-methyl-D\x=req-\ glucose, maltose, sucrose or maltitol into the intestinal lumen, but not after infusion of solutions of D-fructose, D-fucose, D-mannose, D-xylose or lactose. The increases in plasma glucagon-like peptide-1 concentration correlated with the corresponding increases in glucagon-like immunoreactivity induced by these sugars. The plasma glucose level of the regional mesenteric vein increased significantly from the basal level after instillation of D\ x=r eq-\ glucose, but not after instillation of other sugars. It is suggested that cells of the gut have a glucose sensor for release of products of the glucagon gene and that this sensor has specific steric requirements. The sugars that induced glucagon-like peptide-1 release share the molecular features of electron density near C(6), an equatorial hydroxyl at C(2), and an axial hydroxyl at C(1), which could account for their recognition by the glucose sensor to initiate the releases of glucagon-like peptide-1 and glucagon-like immunoreactivity.
Gut glucagon-related peptides are distributed in enteroendocrine L cells throughout the gastroin¬ testinal tract, with highest concentrations localized in the distal small intestine and the colon (1) (2) (3) . The precursor molecule proglucagon contains, in addi¬ tion to the amino acid sequence of the hormone glucagon and glicentin-related polypeptide (proglucagon(l-30)), a sequence of further 96 amino acids. The latter fragment contained two glucagon-like peptides, glucagon-like peptide (GLP)-l (proglucagon(72-108)) and glucagon-like peptide-2 (proglucagon(126-159)), which were flanked by basic dipeptides, potential post-translational cleavage sites (4, 5) Proglucagon is shown to be processed into glicentin (proglucagon 1-69) (6) and the two glucagon-like peptides in the ileum. Recently, the complete amino acid sequences of human and porcine gut GLP (8, 9) suppresses gluca¬ gon secretion (10, 11) , and inhibits acid secretion (12) . GLP-1 immunoreactivity has been shown to be released into the circulation after a mixed meal and in response to a glucose load (13) . Thus, GLP-1 has been suggested to play an important role in carbohydrate metabolism as an "incretin". How¬ ever, the mechanism of its secretion from the in¬ testinal tract is not known.
To clarify this point with special reference to the mechanism of induction of GLP-1 release from the gut by sugars, we compared the effects of various sugars, sugar derivatives, and a sugar alcohol on the release of GLP-1 from ileal loops of dogs with the levels of glucagon-like immunoreactivity (GLI) release.
Materials and Methods
Ninety-eight healthy mongrel dogs of both sexes, weigh¬ ing 10 We examined the relationship of increment of the plasma immunoreactive GLP-1 concentration to that of GLI during instillations of the various sugars into loops of the ileum. As shown in Fig. 3 (17) . D-glucose has been reported to stimulate the secretion of GLP-1 from isolated perfused porcine ileum (18) and in man (13) (14) , it seems likely that GLIsecreting cells in the ileum have sugar sensors, since the a-anomer of glucose is less well metabolized than the ß-anomer, assuming that sugars are me¬ tabolized by these cells in a similar way as in pan¬ creatic islets (21) . On the same assumption, galac¬ tose and 3-0-methyl-D-glucose, which are poorly metabolized (22) release? D-glucose exists primarily as a six-member ring with a chair conformation in which the hy¬ droxyl groups at C-2, C-3 and C-4 are in the equa¬ torial position (Fig. 4) . ci-D-glucose with a hydroxyl group at C-l in the axial position, has been re¬ ported to be more potent than ß-D-glucose in stim¬ ulating GLI release, suggesting that the a-anomer is recognized better than the ß-anomer. D-mannose, which does not stimulate GLI or GLP-1 re¬ lease, gives further insight into the steric require¬ ment at C-2 for recognition of a hexose, because it has an axial instead of an equatorial hydroxyl group at C-2. Thus, for recognition, the hexose must have an equatorial hydroxyl group at C-2. The inability of D-mannose to induce release of GLI or GLP-1 is in contrast to its ability to stimulate insulin release from pancreatic B-cells (24, 25) and to suppress arginine-induced glucagon release from pancreatic A-cells (26) . Even This conclusion is compatible with the fact that Dglucose shows a-anomeric stereospecificity for GLI release (14) .
In conclusion, biological and structural studies suggest that cells in the gut inducing release of products of the glucagon gene from the gut have a glucose sensor with specific steric requirements. Sugars that induce the releases of GLI and GLP-1 share a common molecular architecture that could account for their recognition by this glucose sensor.
